Biological vascular grafts

Area of Science:

• Vascular Surgery
• Biomaterials Science
• Regenerative Medicine

Background:

• Biological bypass grafts are alternatives to autogenous veins in lower extremity revascularization.
• Graft failure is often due to immunogenicity and biodegradation.
• Cryopreservation and glutaraldehyde tanning are methods to improve graft viability and reduce immune response.

Purpose of the Study:

• To evaluate the efficacy of biological bypass graft materials, specifically umbilical vein grafts, as alternatives to autogenous vein grafts.
• To assess the impact of glutaraldehyde tanning on graft antigenicity, tensile strength, and sterilization.
• To report long-term patency and limb salvage rates for umbilical vein grafts.

Main Methods:

• Utilizing cryopreserved umbilical vein grafts pretreated with dimethylsulfoxide.
• Employing glutaraldehyde tanning to enhance graft properties.
• Analyzing 5-year patency and cumulative limb salvage data.

Main Results:

• Glutaraldehyde tanning effectively increases tensile strength, masks antigenicity, and sterilizes the umbilical vein graft.
• The 5-year patency rate for these grafts was 67%.
• Cumulative limb salvage rates reached 80% over 5 years.

Conclusions:

• Umbilical vein grafts, processed with glutaraldehyde tanning, represent an effective alternative to autogenous vein grafts.
• These grafts demonstrate significant long-term utility, evidenced by high patency and limb salvage rates.
• Addressing immunogenicity and biodegradation is crucial for successful biological bypass graft applications.